Stockreport

Zentalis Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Zentalis Pharmaceuticals, Inc. - common stock  (ZNTL) 
PDF NEW YORK and SAN DIEGO, April 07, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discove [Read more]